Latent Autoimmune Diabetes in Adults: Evidences for Diabetes Spectrum?
Xiang Yu-fei,Zhao Yun-juan,Zhou Zhi-guang
DOI: https://doi.org/10.3760/cma.j.issn.0366-6999.20122060
IF: 6.133
2013-01-01
Chinese Medical Journal
Abstract:In 1936, Himworth first investigated insulin resistance and non-insulin resistance in diabetes. Then the terminology "type 1 diabetes (T1D)" and "type 2 diabetes (T2D)" were first used in 1951. In 1999, the World Health Organization (WHO) announced the classification of diabetes: as we all known, T1D and T2D.1 This classification is widely accepted and used. However, in clinical practice, it is quite often to find some patients cannot be simply diagnosed as T1D or T2D. In 1974, islet autoantibodies were discovered in the sera in T1D, which provided strong evidence to prove that T1D is an autoimmune disease. Irvine et al2 found that about 11% clinical diagnosed T2D subjects have positive autoantibodies to islet-cell cytoplasm (ICA) in 1977. Later on, Zimmet et al3 introduced the term we all know now, which is "latent autoimmune diabetes in adults (LADA)" to describe the autoantibodies positive phenotypic T2D patients. The Immunology of Diabetes Society (IDS) proposed the diagnosis criteria for LADA:4 1) Adults onset (older than 30 years old); 2) at least 6 months insulin independent after diagnosis; and 3) any positive islets autoantibody. Scientists later found this subtype of diabetes has the feature of both T1D and T2D but not exactly the same as each. Including Korea National Diabetes Program (KNDP) collaboratory Group in Korea,5 Ehime study in Japan,6 Not Insulin-Requiring Autoimmune Diabetes (NIRAD) Study in Italy,7–12 Nord-Trøndelag Health (HUNT) study in Norway,13–15 Action LADA in Europe16–20 and LADA China study in China,21,22 a lot of multicenter studies have been organized to explore the clinical, immunogenetics, and metabolic characteristics of LADA. More and more evidences from LADA indicate that diabetes is a continuous spectrum, from T1D to T2D, and LADA is in the between.23 We now summarize the evidences from beta cell function, autoimmunity, inflammation, metabolism, and genetic background as following. BETA CELL FUNCTION OF LADA IN DIABETES SPECTRUM Beta cell function is the most important clinical index strongly affecting the treatment decision in diabetes care. HUNT study has proved that the need for insulin treatment in LADA is linked to the degree of autoimmunity and beta cell failure.14 The study also showed that LADA and T2D without insulin treatment are phenotypically similar. LADA, at least in the first 6 months after diagnosis is insulin independency.4 It suggests that the beta cell function of LADA is much better than T1D at the diagnosis. If compared with T2D, the beta cell function of LADA is almost 3 fold worse according to our follow up study.24 UK Prospective Diabetes Study Group (UKPDS) showed about 84% less than 35 years old and 34% elder than 55 years old GADA(+) LADA patients developed to insulin dependent period. However, there were only 14% and 5% in GADA(−) T2D.25 This result suggested that LADA had a progressing autoimmunity-mediated beta cell dysfunction before insulin treatment. Several other studies including KNDP collaboratory Group also followed the beta cell function of LADA.5,21 Majority of them showed that beta cell function of LADA is better than T1D but worse than T2D. Moreover, if divided LADA into two subtypes according to the titer of islet autoantibodies, the high titer LADA has a worse beta cell function which is close to T1D, and the low titer LADA has a better beta cell function which is close to T2D.7,14,21 From T1D, LADA to T2D, the beta cell function is gradually increased which showed as a continuous spectrum. AUTOIMMUNE FEATURE OF LADA IN DIABETES SPECTRUM Pancreatic biopsy showed lymphocyte infiltration causes beta cell destruction in T1D.26 Presence of autoantibodies along with islet-reactive T cells in both LADA and classic T1D provides strong evidences that underlying disease process is autoimmunity. Among them, autoantibodies have been used for clinical autoimmune diabetes diagnosis widely. Glutamic acid decarboxylase 65 (GAD65, anti-GAD), the intracy to plasmatic domain of the tyrosine phosphatase-like protein IA-2 (IA-2A), insulin autoantibodies (IAA), and recently identified zinc transporter antibody (ZnT8A) are common in classic autoimmune diabetes.9,27–30 Studies from China showed that IA-2A, IAA and Znt8A were with low positivity in Chinese T1D or LADA.30 Among those islet autoantibodies, GADA appears early and exists in peripheral blood for a long time. Its assay method has been standardized already.28 Thus, GADA has become the main islet autoantibody for LADA screening and the most sensitive autoimmune marker for LADA diagnosis. LADA China Study found that GADA positivity was 5.9% in newly diagnosed Chinese subjects with phenotypic T2D (over 30 years old).21 The clinical characteristics of LADA were correlated with the titer and numbers of autoantibodies.21 It is very interesting that both LADA China study and NIRAD study found a bimodal of GADA titer.7,12,21,31,32 They reported different cutoff point to divide LADA into high titer and low titer subtypes with different clinical features prone to T1D and T2D. With developed T cell assay methods, single T cell activation could be detected as well. Now scientists could detect autoantigen reacted T cells respond to multiple islet proteins in LADA with and without autoantibodies. Goel et al33 investigated the LADA PBMC proliferation to human islet protein. Recently the same group identified a group of phenotypic T2D subjects who had T cells reactive to islet proteins but were negative for islet autoantibodies. Moreover, they observed that T2DM with T cells response to islet proteins had more severe beta cell lesion. This suggested assessing T cell response to specific islet protein was more important than assessing islet autoantibodies alone. Yang et al34 reported T cell activity to carboxypeptidase H (CPH). Treg cells (CD4+CD25+Foxp3+), either numerically or functionally, changed in the autoimmune diabetes such as classic T1D. Recent data from Yang et al35 showed that Tregs were reduced and the expression of Foxp3 in mRNA levels in CD4+ T cells were decreased in LADA patients. All the data above indicated that T cells, either the pathogenic T cells, which could specifically response to islet antigen then cause the beta cell dysfunction directly, or the regulatory T cell, which may suppress pathogenic T cells and was found decreased in LADA, are involved in the pathogenesis of LADA. Recently, the Action LADA study assayed the interferon-γ and interleukin (IL)-13 releasing T cells in T1D, LADA and T2D subjects. They found that under the stimulation of auto-antigen, T1D and LADA patients did not display any differences.36 This suggests that the T cell reaction in LADA and T1D was similar. Zhang et al37 found that compared to T2D and control group, Chinese LADA has more Th1 cells, the Th1/Th2 ratio is much higher than T2D and control group. LADA, as an autoimmune disease, usually accompanies with other autoimmune disease related to classic T1D. Among them, it is quite often to find thyroid autoantibodies positive, which is thyroid peroxidase autoantibodies (TPO-Ab) (16.7%) and TgAb (6.7%) and subclinical thyroid abnormal, which is sub-clinical hypothyroidism (27.4%). About 50.0% high GAD-Ab LADA patients (>0.5) have positive thyroid autoantibodies in a Chinese study.6,38,39 While about 47.1% positive thyroid autoantibodies LADA patients have sub-clinical thyroidism.39 High titer GADA is a strong predictor of the development of thyroid autoimmunity in LADA and T1D in Chinese. Jin et al39,40 also found that similar epitope of GADA in autoimmune diabetes and autoimmune thyroid disease may be the underlined mechanism. In NIRAD study, they evaluated GADA-titer related risk for beta cell and other organ-specific autoimmunity.12 Subjects were characterized for protein tyrosine phosphatase IA-2(IC) and IA-2(256-760), ZnT8, TPO, steroid 21-hydroxylase (21-OH), tissue transglutaminase (tTG), and antiparietal cell (APC) antibodies. A significant decreasing trend was observed from high GADA to low GADA and to T2D subjects for IA-2(256-760), ZnT8, TPO, tTG, and APC antibodies. High GADA titer conferred an odds ratio of 8.6 for TPO compared to low GADA titer LADA.12 CYTOKINES OF LADA IN DIABETES SPECTRUM Although we consider T2D strictly without islet autoantibodies and antigen specific T cells, inflammation now have been demonstrated to play a role in the pathophysiology of T2D. A lot of evidences from humans and animal modes indicate that T2D actually is an inflammatory disease. Inflammatory biomarkers such as high-sensitivity C-reactive protein (hs-CRP), IL-6, and tumor necrosis factor (TNF)-α, were elevated in the peripheral blood of T2D. Recently, with the sera from LADA China Study, Xiang et al22 found that the inflammatory markers, including IL-6 and hs-CRP elevated in LADA. The hs-CRP and adiponectin levels in LADA were similar to T2D. While the IL-6 and lipocalin 2 (LCN2) levels were similar to T1D.22 Action LADA study in Europe also found that IL-6, IL-1RA and TNF-α in either LADA or T1D was lower than T2D subjects.41 Xiao et al42 found fibroblast growth factor 21 (FGF21) in T2D was higher than in LADA and T1D. Action LADA study further measured concentrations of adhesion molecules sE-selectin, soluble intercellular adhesion molecule (sICAM)-1 and soluble vascular cell adhesion molecule (sVCAM)-1, and chemokines CCL2, CCL3 and CCL4 in LADA patients and then compared those cytokines between T1D and T2D. They found that T2D subjects exhibited higher concentrations of adhesion molecules than T1D and LADA.20 CCL2 and CCL4 did not show any significant differences between groups, while CCL3 was higher in LADA and T1D subjects than T2D and controls.20 These data showed that cardiovascular risk factors in T2D were higher than in autoimmune diabetes including T1D and LADA. From different cytokine studies, LADA showed a heterogeneity of altered cytokine levels across the clinical spectrum of diabetes. METABOLIC FEATURE OF LADA IN DIABETES SPECTRUM Inflammatory cytokines may relate to the different metabolic features of diabetes subtypes. HUNT study showed the influence of age, overweight and physical activity on the risk of LADA.43 It demonstrated that increased age, overweight and physical inactivity are strong risk factors for LADA that similar to T2D but not T1D.43 These findings suggest a role for insulin resistance in the pathogenesis of LADA. Chiu et al44 reported that LADA had equivalent insulin resistance compared with BMI matched T2D. Furthermore, Li et al45,46 found that insulin resistance and metabolic syndrome (MetS) were equivalent in both LADA and T2D. However, in Action LADA study, they reported that LADA has a similar MetS frequency as in T1D if excluded glucose.18 The incidence of micro-vascular complications such as retinopathy, nephropathy and neuropathy in LADA is similar to T2D,13 however, the incidence of retinopathy is lower than classic T1D.47,48 For macro-vascular complications, LADA is similar to T2D but higher than T1D.48,49 Younger onset age of classic T1D may affect this result. Overall, more evidences supported that LADA has a similar metabolic feature as T2D. GENETIC BACKGROUND OF LADA IN DIABETES SPECTRUM Does the immune response and clinical progression in diabetes spectrum relate to genetics? The HUNT Study showed that family history of diabetes, although the type of diabetes in the relatives was unknown, was a strong risk factor for the development of LADA.50 Increased frequency of HLA susceptibility alleles has been observed in LADA. Tuomi's study showed that classic T1D was correlated with HLAII alleles, such as DR3, DR4, DQ2 and DQ8.51 The frequency of them from high to low is T1D, LADA and Normal Control.51,52 Lin et al53 found that the susceptible haplotypes of the HLA-DQ gene present a continuous spectrum from classic T1D, through LADA, to T2D in Chinese. In LADA China Study, Zhou et al21 reported that HLA diabetes- susceptible haplotypes were more frequent in LADA, than in both T2D and controls. HLA diabetes-protective haplotypes were less frequent in LADA than in both T2D and controls. Whether or not there are subtle differences between classic T1D and LADA for specific alleles is controversial. UKPDS showed that the frequency of HLA-DR3, DR4 and DR3/4 in LADA was similar to T1D and decreased with the increasing age.54 Case control study about classic T1D related genes such as HLA haplotype, variable number of tandem repeats of the 5′ region of the insulin gene (INS-VNTR),55 cytotoxic T lymphocyte antigen-4 (CTLA-4),56,57 Microsatellite polymorphism in the major histocompatibility complex class I chain-related gene A (MICA) and Znt8 gene plus T2D related gene TCF7L2 and others had already been screened in LADA. Recent studies showed that LADA shares genetic features with both T1DM (HLA,50 INS-VNTR,50,55 and PTPN228,58) and T2D (TCF7L2),11,59–61 which justified considering LADA as an admixture of the two major types of diabetes.62 One meta-analysis demonstrates that the effect size of T2DM related TCF7L2 rs7903146 polymorphism is similar for LADA and type 2 diabetes.59 This gene effect on diabetes risk may be modulated by BMI.59 Recently, Li et al63 first studied the epigenetic feature of LADA and found that DNA methylation levels are altered in CD4+ T cells in LADA patients, which may contribute to disease onset and progression by affecting the expression of autoimmune-related genes. SUMMARY The classification of diabetes is controversial in clinical practice due to some gray area.16 Simply dividing diabetes into T1D and T2D in fact limits our knowledge to the real mechanism of the disease.64 From evidences found in LADA, we realized that this subtype of diabetes has the clinical feature of both T1D and T2D. The classic classification of diabetes only notices the extreme type of diabetes, which may be on the two ends of the whole diabetes spectrum.16 It is not odd to see that obesity, insulin resistance, and inflammation, previously considered the feature of T2D, found in islet autoantibody positive, insulin dependency T1D subjects. LADA has the autoimmune feature prone to T1D but metabolic and inflammatory feature prone to T2D. Genetic study in some part explained this phenomena that T1D risk gene HLA-DQ/DR (immune related) and T2D risk gene TCF7L2 (BMI related) were both with high frequency in LADA. Those evidences strong suggest that LADA is in the middle of the diabetes spectrum. We should open our mind to consider the classification of diabetes. Further mechanism study about LADA and other types of diabetes is the most direct method to supply solid evidences for diabetes classification.64 Acknowledgement: We thank LADA China Study group members who helped contribute the data for Chinese LADA subjects.